Safe medication prescribing and monitoring in the outpatient setting.
作者信息
Shojania Kaveh G
机构信息
Clinical Epidemiology Program, Ottawa Health Research Institute, Department of Medicine, University of Ottawa, Ottawa, Ont.
出版信息
CMAJ. 2006 Apr 25;174(9):1257-8. doi: 10.1503/cmaj.050984.
Abstract
摘要
相似文献
1
Safe medication prescribing and monitoring in the outpatient setting.门诊环境中的安全用药处方与监测。
CMAJ. 2006 Apr 25;174(9):1257-8. doi: 10.1503/cmaj.050984.
2
Olanzapine pediatric overdose.奥氮平儿科过量用药。
Ann Emerg Med. 1999 Aug;34(2):292-3. doi: 10.1016/s0196-0644(99)70250-7.
3
Cetirizine.
Nurs Times. 2005;101(19):55.
4
The role of divalproex plus olanzapine in outpatient mixed-episode bipolar I disorder.
J Clin Psychiatry. 2009 Nov;70(11):1548-50. doi: 10.4088/JCP.09com05470yel.
5
The Schizophrenia Outpatient Health Outcomes (SOHO) study: 3-year results of antipsychotic treatment discontinuation and related clinical factors in Spain.精神分裂症门诊健康结局（SOHO）研究：西班牙抗精神病药物治疗中断的3年结果及相关临床因素
Eur Psychiatry. 2008 Jan;23(1):1-7. doi: 10.1016/j.eurpsy.2007.09.008. Epub 2007 Nov 26.
6
Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.精神分裂症的长期抗精神病药物单一疗法：一项泛大陆观察性研究中接受奥氮平、喹硫平、利培酮或氟哌啶醇单一疗法治疗的患者的疾病负担及比较结果
J Clin Psychiatry. 2008 Dec;69(12):1901-15. Epub 2008 Sep 9.
7
Time to discontinuation and self-discontinuation of olanzapine and risperidone in patients with schizophrenia in a naturalistic outpatient setting.在自然主义门诊环境中，精神分裂症患者停用奥氮平和利培酮的时间及自行停药情况。
J Clin Psychopharmacol. 2008 Feb;28(1):74-7. doi: 10.1097/jcp.0b013e3181602cf3.
8
[The efficacy of cetirizine in the treatment of perennial allergic rhinitis].
Recenti Prog Med. 1999 Jun;90(6):325-6.
9
An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.一项针对使用奥氮平治疗的精神分裂症门诊患者结局的开放性、大型、为期6个月的自然主义研究。
Hum Psychopharmacol. 2011 Jan;26(1):81-5. doi: 10.1002/hup.1173. Epub 2011 Feb 9.
10
Olanzapine plasma concentration, average daily dose, and interaction with co-medication in schizophrenic patients.奥氮平在精神分裂症患者中的血药浓度、平均日剂量及与合并用药的相互作用。
Pharmacopsychiatry. 2004 Mar;37(2):63-8. doi: 10.1055/s-2004-815527.
引用本文的文献
1
CancelRx case study: implications for clinic and community pharmacy work systems.取消 Rx 案例研究：对诊所和社区药房工作系统的影响。
BMC Health Serv Res. 2023 Dec 6;23(1):1360. doi: 10.1186/s12913-023-10396-9.
2
Appropriateness of ambulatory prescriptions in Taiwan: translating claims data into initiatives.台湾地区门诊处方的适宜性：将索赔数据转化为行动。
Int J Clin Pharm. 2012 Feb;34(1):72-80. doi: 10.1007/s11096-011-9589-8. Epub 2011 Dec 3.
3
The incidence and nature of drug-related hospital admission: A 6-month observational study in a tertiary health care hospital.与药物相关的住院情况的发生率及性质：在一家三级医疗保健医院进行的为期6个月的观察性研究。
J Pharmacol Pharmacother. 2011 Jan;2(1):17-20. doi: 10.4103/0976-500X.77095.
4
Incidence, severity and preventability of medication-related visits to the emergency department: a prospective study.与药物相关的急诊科就诊的发生率、严重程度及可预防性：一项前瞻性研究
CMAJ. 2008 Jun 3;178(12):1563-9. doi: 10.1503/cmaj.071594.
5
Safe prescribing.安全处方
CMAJ. 2007 Jan 2;176(1):66; author reply 66-7. doi: 10.1503/cmaj.1060105.
本文引用的文献
1
The quality of pharmacologic care for vulnerable older patients.弱势老年患者的药物治疗护理质量。
Ann Intern Med. 2004 May 4;140(9):714-20. doi: 10.7326/0003-4819-140-9-200405040-00011.
2
Adverse drug events in ambulatory care.门诊医疗中的药物不良事件。
N Engl J Med. 2003 Apr 17;348(16):1556-64. doi: 10.1056/NEJMsa020703.
3
Incidence and preventability of adverse drug events among older persons in the ambulatory setting.门诊环境中老年人药物不良事件的发生率及可预防性
JAMA. 2003 Mar 5;289(9):1107-16. doi: 10.1001/jama.289.9.1107.
Zotero 插件